The European Organisation for Research and Treatment of Cancer: a unique pan-European network

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.6, Iss.1, 2005-01, pp. : 141-145

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cost-Utility Analysis of Treatment with Olanzapine Compared with Other Antipsychotic Treatments in Patients with Schizophrenia in the Pan-European SOHO Study

By Knapp Martin Windmeijer Frank

PharmacoEconomics, Vol. 26, Iss. 4, 2008-01 ,pp. : 341-358

Adis International

Access to resources Recommend Favorite

Implications of the European Organisation for Research And Treatment Of Cancer (EORTC) Guidelines on the Use of Granulocyte Colony-Stimulating Factor (G-CSF) for Lymphoma Care

By Pettengell Ruth

Clinical Drug Investigation, Vol. 29, Iss. 8, 2009-08 ,pp. : 491-513

Adis International

Access to resources Recommend Favorite

Relevance of an Academic GMP Pan-European Vector Infra-Structure (PEVI)

Current Gene Therapy, Vol. 10, Iss. 6, 2010-12 ,pp. : 414-422

Bentham Science Publishers

Access to resources Recommend Favorite

Proposals for a European Research Council

Reproductive BioMedicine Online, Vol. 9, Iss. 4, 2004-10 ,pp. : 403-403

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

Health-related quality-of-life results from PALETTE: A randomized, double-blind, phase 3 trial of pazopanib versus placebo in patients with soft tissue sarcoma whose disease has progressed during or after prior chemotherapy—a European Organization for research and treatment of cancer soft tissue and bone sarcoma group global network study (EORTC 62072)

Cancer, Vol. 121, Iss. 17, 2015-09 ,pp. : 2933-2941

Blackwell Publishing

Access to resources Recommend Favorite